We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Association of Circulating Chemerin Levels and Arterial Stiffness

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2011 by Korea University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01293929
First Posted: February 11, 2011
Last Update Posted: March 4, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Korea University
  Purpose
Chemerin is a novel adipokine that might provide a link between chronic inflammation and obesity. Pulse wave velocity(PWV) is a useful method for examining arterial stiffness, meaning early-stage atherosclerosis. Therefore, in the present study, the investigators examined the relationship between circulating chemerin and arterial stiffness measured using PWV in obese persons.

Condition
Obesity Atherosclerosis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Korea University:

Primary Outcome Measures:
  • The difference of serum chemerin level between obese and non-obese groups [ Time Frame: at the time of initial enrollment (4weeks) ]
    serum chemerin levels of all participants were by determined by an enzyme-linked immunosorbent assay (ELISA) kit (Biovender Laboratory Medicine Inc., Modrice, Czech Republic)


Secondary Outcome Measures:
  • The correlation of serum chemerin levels with arterial stiffness [ Time Frame: at the time of enrollment (4 weeks) ]
    Arterial stiffness was measure using a Colin Waveform Analyser (model BP-203RPE II; Colin, Komaki, Japan). It was expressed as branchial ankle pulswe wave velocity (baPWV)


Estimated Enrollment: 120
Study Start Date: February 2011
Estimated Study Completion Date: March 2011
Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Non- obese group
Obese group

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Obese and age, gender matched non-obese group who underwent a medical health check in the Korea University Guro hospital
Criteria

Inclusion Criteria:

  • Self referred persons for visiting routine medical check in our clinic

Exclusion Criteria:

  • Malignancy
  • Severe renal or hepatic disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01293929


Contacts
Contact: Hye Jin Yoo 82226263045 deisy21@naver.com

Locations
Korea, Republic of
Hye Jin Yoo Recruiting
Seoul, Korea, Republic of
Contact: Hye Jin Yoo    82226263045    deisy21@naver.com   
Sponsors and Collaborators
Korea University
  More Information

Responsible Party: Hye Jin Yoo, Korea university
ClinicalTrials.gov Identifier: NCT01293929     History of Changes
Other Study ID Numbers: A102065-1011-1070100
First Submitted: February 10, 2011
First Posted: February 11, 2011
Last Update Posted: March 4, 2011
Last Verified: January 2011

Additional relevant MeSH terms:
Atherosclerosis
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases